Journals / Bağımlılık Dergisi / 2006 / Cilt: 7 - Sayı: 3

Cannabinoids: A review neurobiological and neuropsychopharmacological bases of dependence and rewarding effects

Kannabinoidler: Ödüllendirici ve bağımlılık yapıcı etkilerinin nörobiyolojisi ve nöropsikofarmakolojisi üzerine bir gözden geçirme

Pages
140–149
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The objective of this review is to evaluate the results of various animal models, such as drug-discrimination, conditioned place preference, self-administration, and precipitated withdrawal, currently in use to facilitate our understanding of the rewarding and addictive properties of cannabinoids, and of the neurobiological mechanisms that may underlie these properties.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cannabinoids have been associated with a wide range of pharmacological effects, some of which have potential therapeutic benefit while others result in negative outcomes, such as abuse and dependence.
📊
Key Findings & Data:Cannabis is the most commonly used illicit substance in the world, but only recently reliable preclinical models have become available for investigating the rewarding and addictive properties of its primary psychoactive constituent, AMetrahydrocannabinol (A9THC).
💡
Conclusion & Impact:The objective of this review is to evaluate the results of various animal models, such as drug-discrimination, conditioned place preference, self-administration, and precipitated withdrawal, currently in use to facilitate our understanding of the rewarding and addictive properties of cannabinoids, and of the neurobiological mechanisms that may underlie these properties.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cannabinoids have been associated with a wide range of pharmacological effects, some of which have potential therapeutic benefit while others result in negative outcomes, such as abuse and dependence. Cannabis is the most commonly used illicit substance in the world, but only recently reliable preclinical models have become available for investigating the rewarding and addictive properties of its primary psychoactive constituent, AMetrahydrocannabinol (A9THC). Starting with the discovery of an endogenous brain cannabinoid system with specific receptors and their endogenous ligands, and through the use of the tools such as specific CB1 receptor antagonist, SR141716A, and various transgenic models, considerable advances have been made in understanding the mechanisms underlying cannabinoid dependence. The objective of this review is to evaluate the results of various animal models, such as drug-discrimination, conditioned place preference, self-administration, and precipitated withdrawal, currently in use to facilitate our understanding of the rewarding and addictive properties of cannabinoids, and of the neurobiological mechanisms that may underlie these properties.

Özet

Kannabinoidler ağrıyı gidermek ve bulantı-kusmayı önlemek gibi terapötik yararı olan etkilerin yanı sıra bağımlılığa yol açmak gibi olumsuz etkilere de sahiptir. Esrar, günümüzde en yaygın kötüye kullanılan yasadışı madde olmakla birlikte, bu bitkinin temel psikoaktif maddesi olan A9--Tetrahidrokannabinolün ödüllendirici etkisi ve bununla doğrudan ilişkili olan bağımlılık oluşturucu etkisinin araştırılmasında deneysel modellerin kullanımı daha yakın tarihlere dayanmaktadır. Özgül kanabinoid reseptörlerinin ve bu reseptörlere bağlanan endojen ligandların keşfinden sonra ve seçici kannabinoid CB1 reseptör antagonisti SR141716A ve transgenik modellerin sağladığı olanaklarla son yirmi yılda kanabinoidlerin ödüllendirici ve bağımlılık yapıcı etkilerinin altında yatan nöronal etki düzenekleri konusunda hızlı bir ilerleme kaydedilmiştir. Bu derleme makalede, ilaç diskriminasyon yöntemi, koşullu yer tercihi, kendine-uygulama ve antagonistic presipite edilmiş yoksunluk sendromu gibi hayvan modelleri kullanılarak kannabinoidlerin ödüllendirici ve bağımlılık yapıcı etkileri ve bu etkilerin altında yatan nöronal etki düzenekleri konusunda yapılan çalışmaların olabildiğince kapsamlı bir taraması ve değerlendirilmesi amaçlanmıştır

🔖

Cite This Article

ALICI, T., UZBAY, T. İ. (2022). Cannabinoids: A review neurobiological and neuropsychopharmacological bases of dependence and rewarding effects. Bağımlılık Dergisi, Cilt: 7 - Sayı: 3, 140–149. https://ajindex.com/articles/459157

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Hillard CH, Harris RA, Bloom AS. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: Fluorescence studies. J Pharmacol Exp Ther 1985; 232:579-588
  2. Dewey WL. Cannabinoid pharmacology. Pharmacol Revl 986; 38: 151-178
  3. Howlett AC, Qualy JM, Khachatrial LL. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharm 1986; 29: 307-313
  4. Devane WA, Dysarz FAI, Johnson MR, Melvin LS, Howlett AC. Determination and rization of a cannabinoid receptor in rat brain. Mol Pharm 1988; 34: 605-613
  5. Matsuda LA, Lolait SJ, Brownstein MJ, Young AL, Bonner TA. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561-564
  6. Herkenham M, Lynn AB, Johnson MR et al. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 1991; 11: 563-583
  7. Breivogel CS, Griffin D, Di Marzo V, Martin BR. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 2001; 60:155-163
  8. Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 1997; 74: 129-180
  9. Breivogel CS, Childers S.R. The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 1998; 5: 417-431
  10. Munro, S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61-65
  11. Wiley JL. Cannabis: discrimination of "internal bliss". Pharmacol Biochem Behav 1999; 64: 257-260
  12. Alici T, Kayir H, Aygoren MO, Sağlam E, Uzbay IT. Discriminative stimulus properties of tianeptine. Psychopharmacology 2006; 183: 446-451
  13. Prus AJ, Philibin SD, Pehrson AL, Porter JH. Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle. Behav Pharmacol 2006; 17: 185-194
  14. Uzbay İ.T. Psikofarmakolojinin Temelleri ve Deneysel Araştırma Teknikleri. Ankara: Çizgi Tıp Yayınevi, 2004: 125-128, 153-154
  15. Wiley JL, Huffman JW, Balster RL, Martin BR. Pharmacological specificity of the discriminative stimulus effects of delta-9-tetrahydro-cannabinol in rhesus monkeys. Drug Alcohol Depend 1995; 40: 81-86
  16. Barrett RL, Wiley JL, Balster RL, Martin BR. Pharmacological specificity of the discriminative stimulus effects of delta-9-tetrahydrocan-nabinol in rats. Psychopharmacology 1995; 118:419-424
  17. Compton DR